RA Capital Management, L.P. 13D and 13G filings for Rhythm Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
RA Capital Management, L.P. | 6,084,412 9.950% |
754,000 (+14.15%) |
Filing |
| 2024-02-14 5:01 pm Sale |
2023-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
RA Capital Management, L.P. | 5,330,412 9.000% |
-185,655 (-3.37%) |
Filing |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
RA Capital Management, L.P. | 5,516,067 9.800% |
645,000 (+13.24%) |
Filing |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
RA Capital Management, L.P. | 4,871,067 9.700% |
692,000 (+16.56%) |
Filing |
| 2021-02-16 4:39 pm Sale |
2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
RA Capital Management, L.P. | 4,179,067 9.500% |
-1,243,245 (-22.93%) |
Filing |